Opus Genetics, Inc. (IRD)
4.60
+0.15
(+3.37%)
USD |
NASDAQ |
Sep 03, 16:00
4.65
+0.05
(+1.09%)
After-Hours: 20:00
Opus Genetics Debt to Equity Ratio : -2.788 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.788 |
| March 31, 2026 | -0.5658 |
| December 31, 2025 | 0.0736 |
| September 30, 2025 | 0.179 |
| June 30, 2025 | 0.0572 |
| March 31, 2025 | 3.714 |
| December 31, 2024 | 2.802 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0124 |
| December 31, 2021 | 0.0242 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| September 30, 2020 | 0.0176 |
| June 30, 2020 | 0.0194 |
| March 31, 2020 | 0.018 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0204 |
| September 30, 2019 | 0.02 |
| June 30, 2019 | 0.0196 |
| March 31, 2019 | 0.0185 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics, Inc. | 0.0122 |
| Praxis Precision Medicines, Inc. | 0.0008 |
| Faeth Therapeutics, Inc. | 0.0033 |
| Jade Biosciences, Inc. | 0.0014 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 92.97M |
| Total Liabilities (Quarterly) | 105.95M |
| Shareholders Equity (Quarterly) | -12.99M |
| Current Ratio | 12.19 |
| Net Debt Paydown Yield | -1.02% |